Hidradenitis suppurativa patient requiring cardiac procedure with inguinal access: Case management with ertapenem.
需要腹股溝進入的Hidradenitis suppurativa患者進行心臟手術:使用ertapenem的案例管理。
SAGE Open Med Case Rep 2024-08-21
Two cases of linagliptin-associated bullous pemphigoid resulting in sepsis and endocarditis.
Linagliptin相關的兩例致敗血症和心內膜炎的大疱性類天疱瘡。
BMJ Case Rep 2024-05-21
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Bimekizumab在中重度汗腺炎擴散性性膿瘡患者中的療效和安全性(BE HEARD I和BE HEARD II):兩項48週、隨機、雙盲、安慰劑對照、多中心3期試驗。
Lancet 2024-05-25
兩個第三階段試驗 BE HEARD I 和 II 證實 bimekizumab 對中重度汗腺炎患者有效且安全。與安慰劑相比,bimekizumab 顯著改善患者症狀,且應答率更高,持續至48週。不良事件輕微,無新安全問題。bimekizumab 耐受性佳,臨床效果顯著,適合治療汗腺炎患者。
PubMedDOI
Dysbiosis and <i>Staphylococcus</i> species over representation in the exit site skin microbiota of hemodialysis patients carrying tunneled cuffed central venous catheter.
血液透析患者携带隧道套袖中心靜脈導管,出口部位皮膚微生物群中的菌群失調及<i>Staphylococcus</i>屬菌種過度代表。
Ren Fail 2024-06-24